LDS/Medical Tests/G6PC (Glucose-6-phosphatase, Catalytic Subunit), Glycogen Storage Disease Type 1 (von Gierke Disease) Gene Mutation Analysis

G6PC (Glucose-6-phosphatase, Catalytic Subunit), Glycogen Storage Disease Type 1 (von Gierke Disease) Gene Mutation Analysis

Includes Glycogen Storage Disease Type 1a and Glycogen Storage Disease Type 1b. Glycogen storage disease type I (GSDI) is an autosomal recessive disorder affecting 1:100,000 individuals with a carrier rate of 1:50. It is the most common glycogen storage disease. GSDI is a deficiency in the enzyme glucose-6-phosphatase, which maintains normal blood glucose during fasting. GSDI is a disease characterized by an accumulation of glycogen and fat in the kidneys and liver, resulting in enlargement of these two organs. In untreated infants, severe hypoglycemia, hepatomegaly, lactic acidosis, hyperuricemia, hyperlipidemia, and hypoglycemic seizures are observed. Affected children usually have thin extremities, short stature, extended abdomen, and ‘doll-like’ fat cheeks. Long term complications of GSDI if left untreated include: short stature, delayed puberty, renal disease, osteoporosis, gout, and pulmonary hypertension.

Clinical testing strategies for GSDI include: 1) confirmation testing to diagnose the disease, 2) presymptomatic, predictive testing of carrier status, and 3) prenatal testing to determine status of a fetus with a family history of GSDI. Confirmation of disease status provides proper patient care and genetic information for at-risk relatives. Predictive testing determines genetic risk for individuals who have a family history of GSDI. Prenatal and carrier testing can be performed if both disease-causing alleles are identified in the family.

GSDI is caused by mutations in the glucose-6-phosphatase catalytic subunit (G6PC) gene located on chromosome 17, specifically the 17q21 region. A critical role of the G6PC gene is to help maintain normal blood glucose levels during fasting. No non-GSDI phenotypes are found to be associated with mutations for GSDI.

One way to diagnose GSDI is by molecular genetic testing of the G6PC gene. Molecular testing such as targeted mutation analysis and DNA sequence analysis is used to determine the mutations. The molecular characterization of G6PC mutations provides key factors for detection and predictive patient impacts. The following are ethnic-specific mutations:

  • p.Arg83Cys (European origin 32%, Jewish 93%-100%)
  • p.Arg83His (Chinese 38%)
  • c.378_379dupTA (Hispanic 50%)
  • c.648G>T (Japanese 88%, Chinese 36)
  • c.79delC, p.Gly188Arg, and p.Gln347X (European origin 21%)
  • Carrier testing for individuals of Ashkenazi Jewish ancestry
  • Diagnose Glycogen Storage Disease
  • Confirmation of disease diagnosis
  • Prenatal diagnosis
  • Determine carrier status

Heterozygous mutation indicates carrier status.

Homozygous mutation indicates disease.

Interpretive report provided by test laboratory for genetic testing.

Chemistry Reference Ranges (each laboratory should establish its own ranges): Normal
· Glucose: 70-120 mg/dL
· Lactic Acid: 0.5-2.2 mmol/L
· Uric Acid: 2.0-5.0 mg/dL
· Triglycerides: 150-200 mg/dL
· Cholesterol: 100-200 mg/dL

Abnormal
· Glucose: <60mg/dL
· Lactic Acid: >2.5 mmol/L
· Uric Acid: >5.0 mg/dL
· Triglycerides: > 250 mg/dL
· Cholesterol: >200 mg/dL
 

 

Genetic analysis: Targeted mutation analysis including p.Arg83Cys, p.Arg83His, c.378_379dupTA , c.648G>T , c.79delC, p.Gly188Arg, and p.Gln347X. Sequence Analysis (Full gene sequence analysis). 

Whole blood collected in tubes with anticoagulant, Buccal swab. Prenatal specimens: Amniotic fluid or chorionic villi (CV). Transport of all specimens refrigerated at 4°C.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days

 

Serum glucose, bicarbonate, lactic acid, uric acid, triglycerides, Liver profile, Liver biopsy, decreased glucose-6-phosphatase activity, Glycogen stimulation test, glucose levels stable, lactic acid levels increase, Ashkenazi Jewish panel.
Approximately 1-2 weeks.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login